340B Drug Pricing Program
The AHA today said that a recent study published in the New England Journal of Medicine “fails to draw meaningful, valid conclusions” about the 340B Drug Pricing Program “due to constraints and flaws” in the methodology.
The 340B Drug Savings Program provides eligible providers, many of which are hospitals, with resources to maintain vital services in their communities and to provide additional services to their patients. A recent study published in the New England Journal of Medicine alleges that the 340B program…
Click below for recordings of past members-only 340B alliance calls.
The AHA, joined by the Association of American Medical Colleges and America's Essential Hospitals, today urged a federal appeals court to expedite their appeal of a lower court’s December dismissal of the groups’ lawsuit that sought to prevent Medicare payment cuts for many hospitals in the 340B…
Plaintiffs-Appellants, three hospital associations and three hospital systems, move to expedite this appeal from an order dismissing Appellants' complaint and denying a preliminary injunction that would have suspended implementation on January 1, 2018, of a new HHS rule drastically reducing payment…
The House Energy and Commerce Committee yesterday released a report on the 340B Drug Pricing Program. “The 340B program is an important program that enjoys strong bipartisan support in Congress,” the report says.
The American Hospital Association, the Association of American Medical Colleges and America's Essential Hospitals today formally notified the court of their intent to appeal the district court’s Dec. 29 decision dismissing the groups’ lawsuit that sought to prevent Medicare payment cuts for many…
It’s a new year but Congress has some old business to attend to—including many critical hospital and health system priorities. Both Houses of Congress will be back in session next week. Front and center is legislation to keep the government open past January 19.